LifeStance Health Group, Inc. (LFST)

Market Cap	2.49B
Revenue (ttm)	1.37B
Net Income (ttm)	-9.12M
Shares Out	389.00M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	219.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,762,049
Open	6.28
Previous Close	6.31
Day's Range	6.16 - 6.42
52-Week Range	3.74 - 8.30
Beta	1.15
Analysts	Strong Buy
Price Target	9.00 (+40.63%)
Earnings Date	Nov 6, 2025

About LFST

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-tra...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Jun 10, 2021
• Employees: 10,218
• Stock Exchange: NASDAQ
• Ticker Symbol: LFST
• Website: https://lifestance.com

Financial Performance

In 2024, LifeStance Health Group's revenue was $1.25 billion, an increase of 18.50% compared to the previous year's $1.06 billion. Losses were -$57.44 million, -69.16% less than in 2023.

Analyst Summary

According to 6 analysts, the average rating for LFST stock is "Strong Buy." The 12-month stock price target is $9.0, which is an increase of 40.63% from the latest price.

Price Target

$9.0

(40.63% upside)

Analyst Consensus: Strong Buy